4-Hydroxyisoleucine

4-Hydroxyisoleucine is a non-proteinogenic amino acid derived from fenugreek seeds that enhances glucose-dependent insulin secretion. This compound activates pancreatic beta cells to improve glucose metabolism and insulin sensitivity.

Origin & History

4-Hydroxyisoleucine is a non-proteinogenic amino acid derivative found naturally in fenugreek seeds. It is extracted from these seeds as a white crystalline powder and belongs to the chemical classes of amino alcohols and α-amino acids.

Historical & Cultural Context

There are no historical or traditional medicinal uses specified in the available research for 4-hydroxyisoleucine.

Health Benefits

• Potential antidiabetic activity is noted, though no specific studies or evidence quality is provided.

How It Works

4-Hydroxyisoleucine enhances glucose-dependent insulin secretion by directly stimulating pancreatic beta cells through calcium-dependent pathways. The compound increases intracellular calcium concentrations in beta cells, triggering insulin release only in the presence of elevated glucose levels. This glucose-dependent mechanism helps prevent hypoglycemic episodes while improving overall insulin sensitivity.

Scientific Research

No human clinical trials, RCTs, or meta-analyses are available for 4-hydroxyisoleucine. Consequently, no PMIDs or detailed studies are referenced in the research.

Clinical Summary

Limited clinical research exists on isolated 4-hydroxyisoleucine supplementation in humans. Most studies have been conducted using fenugreek extracts containing this compound, showing modest improvements in glucose control in small trials of 10-50 participants. Animal studies demonstrate more pronounced antidiabetic effects, but human data remains insufficient to establish definitive therapeutic benefits. The current evidence quality is considered preliminary and requires larger, well-controlled trials.

Nutritional Profile

4-Hydroxyisoleucine is a non-proteinogenic amino acid and bioactive compound, not a conventional nutritional ingredient. It is not a source of macronutrients, vitamins, or minerals in any meaningful dietary sense. As a modified branched-chain amino acid (a hydroxylated derivative of L-isoleucine), it contains the basic amino acid backbone (molecular weight: 147.17 g/mol, molecular formula: C6H13NO3). It is found naturally in fenugreek seeds (Trigonella foenum-graecum) at concentrations of approximately 0.15–1.5% of dry seed weight (roughly 1.5–15 mg/g dried seed), representing the primary natural dietary source. The compound exists predominantly in the (2S,3R,4S) stereoisomeric form in fenugreek, which is considered the most biologically active configuration. Bioactive concentration: standardized fenugreek extracts used in research typically contain 20–40% 4-Hydroxyisoleucine by weight. It does not contribute caloric value in the amounts typically encountered. Bioavailability data in humans is limited, but animal studies suggest intestinal absorption occurs; it is believed to act directly on pancreatic beta cells and peripheral tissues to modulate insulin secretion. No significant vitamin, mineral, or fiber content is associated with the isolated compound itself.

Preparation & Dosage

No clinically studied dosage ranges or forms have been identified. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Fenugreek, berberine, alpha-lipoic acid, chromium, cinnamon

Safety & Interactions

4-Hydroxyisoleucine appears generally well-tolerated based on limited human data, though comprehensive safety studies are lacking. The compound may enhance insulin sensitivity, potentially requiring dose adjustments for diabetes medications to prevent hypoglycemia. Gastrointestinal side effects like nausea or diarrhea have been reported with fenugreek extracts containing this compound. Safety during pregnancy and breastfeeding has not been established.